Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses

Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis

(2023) Carlo C. Quattrocchi et al.   INVESTIGATIVE RADIOLOGY

Use of Real-Life Safety Data From International Pharmacovigilance Databases to Assess the Importance of Symptoms Associated With Gadolinium Exposure

(2022) Imran Shahid et al.   INVESTIGATIVE RADIOLOGY

Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats

(2021) Simona Bussi et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Comparison of Human Tissue Gadolinium Retention and Elimination between Gadoteridol and Gadobenate

(2021) Masahiro Kobayashi et al.   RADIOLOGY

Gadolinium Tissue Distribution in a Large-Animal Model after a Single Dose of Gadolinium-based Contrast Agents

(2021) Henning Richter et al.   RADIOLOGY

Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term

(2021) Robert J. McDonald et al.   RADIOLOGY

Gadolinium Deposition Safety: Seeking the Patient’s Perspective

(2020) C.A. Mallio et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Human Hair as a Possible Surrogate Marker of Retained Tissue Gadolinium

(2020) Makoto Hasegawa et al.   INVESTIGATIVE RADIOLOGY

Within-network brain connectivity in Crohn’s disease patients with gadolinium deposition in the cerebellum

(2020) Carlo A. Mallio et al.   NEURORADIOLOGY

Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies

(2020) Carlo A. Mallio et al.   NEURORADIOLOGY

Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

(2020) Jeffrey C. Weinreb et al.   RADIOLOGY

Impact of Brain Irradiation, Chemotherapy, and Presence of Primary Brain Tumors on Changes in Signal Intensity after Exposure to Gadolinium-based Contrast Agents

(2019) Carlo Augusto Mallio et al.   RADIOLOGY

Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist’s Primer

(2019) Mahan Mathur et al.   RADIOGRAPHICS

The Issue of Gadolinium Retained in Tissues

(2018) Enza Di Gregorio et al.   INVESTIGATIVE RADIOLOGY

Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance ® ) to neonatal and juvenile rats

(2018) Simona Bussi et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

A Structured Survey on Adverse Events Occurring Within 24 Hours After Intravenous Exposure to Gadodiamide or Gadoterate Meglumine

(2018) Marco Parillo et al.   INVESTIGATIVE RADIOLOGY

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats

(2017) Simona Bussi et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Gadolinium-based contrast agents: A comprehensive risk assessment

(2017) Tyler J. Fraum et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts

(2016) Yumi Ozawa et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function

(2016) Donna R. Roberts et al.   INVESTIGATIVE RADIOLOGY

Presumed Gadolinium Toxicity in Subjects With Normal Renal Function

(2016) Richard C. Semelka et al.   INVESTIGATIVE RADIOLOGY

Macrocyclic and Other Non–Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue

(2016) Nozomu Murata et al.   INVESTIGATIVE RADIOLOGY

Self-reported gadolinium toxicity: A survey of patients with chronic symptoms

(2016) Lauren M.B. Burke et al.   MAGNETIC RESONANCE IMAGING

Gadolinium deposition disease: Initial description of a disease that has been around for a while

(2016) Richard C. Semelka et al.   MAGNETIC RESONANCE IMAGING

Gadolinium-Associated Plaques

(2015) Robert M. Gathings et al.   JAMA Dermatology

Stimulation of Fibroblast Proliferation by Insoluble Gadolinium Salts

(2011) Katherine Bleavins et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Gadolinium Contrast Agent Associated Stimulation Of Human Fibroblast Collagen Production

(2011) Sheila MacNeil et al.   INVESTIGATIVE RADIOLOGY

Persistent activation of dermal fibroblasts from patients with gadolinium-associated nephrogenic systemic fibrosis

(2010) S. Piera-Velazquez et al.   ANNALS OF THE RHEUMATIC DISEASES

Responses of Human Skin in Organ Culture and Human Skin Fibroblasts to a Gadolinium-Based MRI Contrast Agent

(2010) Marissa DaSilva et al.   INVESTIGATIVE RADIOLOGY

A Review of Preclinical Safety Data for Magnevist (Gadopentetate Dimeglumine) in the Context of Nephrogenic Systemic Fibrosis

(2010) Thomas Steger-Hartmann et al.   INVESTIGATIVE RADIOLOGY

Fibroblast Response to Gadolinium

(2010) Narasimharao Bhagavathula et al.   INVESTIGATIVE RADIOLOGY

Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis

(2010) Kevin N. Christensen et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Effect of Different Classes of Gadolinium-based Contrast Agents on Control and Nephrogenic Systemic Fibrosis–derived Fibroblast Proliferation

(2010) Michael Edward et al.   RADIOLOGY

Effects of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents on Human Skin in Organ Culture and Human Skin Fibroblasts

(2009) James Varani et al.   INVESTIGATIVE RADIOLOGY

Regulation of Collagen Turnover in Human Skin Fibroblasts Exposed to a Gadolinium-Based Contrast Agent

(2009) Narasimharao Bhagavathula et al.   INVESTIGATIVE RADIOLOGY

Collagenolytic Activity Is Suppressed in Organ-Cultured Human Skin Exposed to a Gadolinium-Based MRI Contrast Agent

(2009) Patricia A. Perone et al.   INVESTIGATIVE RADIOLOGY

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review

(2008) Marc Port et al.   BIOMETALS

Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions

(2008) Martin A. Sieber et al.   EUROPEAN RADIOLOGY

Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis

(2008) M Edward et al.   JOURNAL OF PATHOLOGY

Quantification of gadolinium in nephrogenic systemic fibrosis: Re-examination of a reported cohort with analysis of clinical factors

(2008) Anand Khurana et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Gadolinium is not deposited in the skin of patients with normal renal function after exposure to gadolinium-based contrast agents

(2008) Alan S. Boyd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY